- Hiring from
- United Kingdom
- Work type
- Hybrid
- Posted
624,682 remote jobs, straight from company career pages
100% free · New jobs every minute
Show job descriptionHide job description
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
Does this inspire you and feel like a fit? Then we would love to have you join us!
Genmab is expanding its footprint across Europe and strengthening its commercial capabilities to bring innovative medicines to more patients. We are looking for an experienced and inspiring Commercial Director to build and lead our UK commercial organization as we prepare to bring cutting-edge oncology treatments to patients across the United Kingdom.
Reporting to the UK General Manager and as a member of the UK Leadership Team, the Commercial Director will lead the UK Marketing and Sales teams. You will be accountable for UK commercial performance across the marketed portfolio and for building and executing launches of a late-stage oncology pipeline in head and neck and gynecologic cancers, working closely with Market Access & Pricing, Medical Affairs, Regulatory, Finance and Supply.
This is a build role: alongside delivering results, you will shape the structure, capability and ways of working of a growing UK commercial team.
Key Responsibilities
- Strategy: Own the UK commercial strategy and brand plans across the portfolio, translating global and European strategy into a UK plan that reflects NHS and devolved-nation realities.
- Performance: Deliver UK net sales, market share and patient-uptake objectives, and lead monthly territory and brand performance reviews.
- Planning and budget: Own the commercial budget and operating expenses, and lead UK commercial input to forecasting, the annual budget, the long-range plan and quarterly business reviews.
- Launch excellence: Build and execute UK launch plans for new assets and indications, with clear launch-readiness milestones from pre-launch through to uptake.
- Future portfolio: Lead UK commercial input to indication and asset planning, including patient-flow analysis, segmentation and go-to-market model recommendations.
- Access partnership: Partner with Market Access & Pricing so commercial plans are built around NICE, SMC and AWMSG outcomes and the realities of the Cancer Drugs Fund and NHS commissioning.
- Customers: Lead a key account management model across Cancer Alliances, NHS Trusts, regional multidisciplinary teams and specialist cancer centers in England, Scotland, Wales and Northern Ireland.
- Stakeholders: Build long-term relationships with senior clinical, NHS and patient-organization stakeholders, and bring customer insight back into UK, European and global strategy.
- Omnichannel: Develop omnichannel and medical-commercial engagement that is compliant, measurable and customer-led.
- People leadership: Lead, coach and develop the Marketing and Sales teams, including second-line managers, and shape commercial structure, capability and recruitment as the portfolio grows.
- Leadership Team: Act as a visible, inclusive member of the UK Leadership Team, deputies for the General Manager where required, and represent the UK in European and global commercial forums.
- Compliance: Ensure full compliance with UK law, the ABPI Code of Practice, PMCPA guidance, NHS regulations and Genmab policies, role-modelling a strong compliance culture.
Your Profile
- Significant UK commercial leadership experience in oncology, as a Business Unit Director, Commercial Director or senior Sales and Marketing leader.
- Proven experience leading both marketing and field sales teams, including second-line managers.
- Experience leading at least one UK oncology launch from pre-launch through to uptake.
- Sound knowledge of the UK oncology reimbursement landscape, including NICE, SMC and AWMSG processes, the Cancer Drugs Fund and NHS England commissioning.
- Budget or P&L accountability, with confidence in forecasting and business planning.
- A track record of influencing in a matrix organization with European and global teams.
- Thorough knowledge of the ABPI Code of Practice.
- Ability to build and develop high-performing, inclusive teams, set clear priorities and make decisions with incomplete data.
- A collaborative, one-team approach with Medical affairs and Market Access, keeping patients at the center of commercial decisions.
- Willingness to travel across the UK and internationally as required.
Desirable
- Experience in head and neck cancer, gynecologic oncology, or antibody-drug conjugates (ADC) and bispecific therapies.
- Experience building a commercial organization within a growing biotech affiliate, alongside large pharmaceutical experience.
- Leadership of hospital-based key account teams across Cancer Alliances and specialist centers.
- A degree in life sciences or business; an MBA or equivalent is an advantage.
What We Offer
- A meaningful role in a purpose-driven biotech company on an exciting growth journey.
- The opportunity to work across local and international teams in a collaborative and dynamic culture.
- Exposure to high-impact commercial operational and strategic activities at both local and EU levels
A hybrid work model with flexibility and personal development support
The proposed gross annual base salary range for this position, in the primary location, based on a full time schedule is:
GBP0.00---0.00The final salary offer will depend on several factors, including your skills, qualifications, and experience.
In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long-term incentives.
When you join Genmab, you become a part of a culture that supports your physical, financial, social, and emotional well-being. Our benefits include, but are not limited to:
- Pension
- Health insurance and wellness benefits
- Paid time off
- Employee support programs
Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.
About Genmab
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock-Your-Socks-Off (KYSO®) antibody medicines.
Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.
Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).
Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed-term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.